🔎 Trials Near Me

홈 › 암 (전체) › 뉴욕

뉴욕의 암 (전체) 임상 시험

암 (전체) 관련 연구 141개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.

뉴욕의 도시

공식 연구 텍스트(영어)

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Roswell Park Cancer Institute, Buffalo
  • Columbia University - Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05382559

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07192471

Registry Study for Radiation Therapy Outcomes

  • New York Proton Center, New York
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT01255748

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07410117

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • The Feinstein Institutes for Medical Research, Lake Success
  • NYU Grossman School of Medicine, New York
  • SUNY Upstate, Syracuse
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05874921

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

  • Women's Cancer Care Associates LLC, Albany
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • 외 12개
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05256225

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

  • Investigative Site, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06881992

A Study of Music Therapy for Anxiety in People With Cancer

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
  • 외 1개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07845422

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07493304

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Icahn School of Medicine at Mount Sinai, New York
  • University of Rochester Medical Center, Rochester
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06989437

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06150157

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • Westchester Medical Center, Valhalla
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07195591

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07612176

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

  • Rockefeller Outpatient Pavilion ( Site 0002), New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06979596

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  • Memorial Sloan Kettering Cancer Center ( Site 4010), New York
  • New York Medical College ( Site 4023), Valhalla
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07630974

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

  • GSK Investigational Site, New Hyde Park
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07277270

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

  • NYU Langone Health, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06311578

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • NYU Langone Medical Center, New York
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

A Study of JNJ-1761981 in Participants With Solid Tumors

  • Montefiore Medical Center, The Bronx
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07525141

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • NYU Langone Medical Center, New York
  • Montefiore Medical Center, The Bronx
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06901531

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

  • Columbia University Irving Medical Center, New York
피험자 모집 중
15세 ~ 24세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07223463

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 4, Buffalo
  • Quetzal Site 2, The Bronx
피험자 모집 중3상
18세 ~ 71세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07504458

Pan Tumor Rollover Study

  • NYU Langone Hematology Oncology Associates-Mineola, Mineola
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03899155

Intratumoral N17350 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07339176

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Northwell Health Monter Cancer Center, Lake Success
  • Northern Westchester Hospital, Mount Kisco
  • Cohen Children's Medical Center, New Hyde Park
  • 외 4개
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535

Prospective Study to Assess a Diagnostic Aid for Cancer

  • Westchester Putnam Gastro, Carmel
  • Associated Gastroenterologists of Central New York, Fayetteville
  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중관찰 연구
45세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07046260

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

  • Roswell Park Comprehensive Cancer Center, Buffalo
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06423950

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • City College of New York (Data Collection AND Data Analysis), New York
  • 외 3개
피험자 모집 중관찰 연구
21세 ~ 80세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT01742143

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • New York Oncology Hematology P.C., Albany
  • Roswell Park Cancer Institute, Buffalo
  • New York University - Langone Medical Center - The Center for Musculoskeletal Care, New York
  • 외 4개
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

  • Memorial Sloan Kettering Cancer Center ( Site 3010), New York
  • New York Medical College ( Site 3023), Valhalla
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06941272

Collection of Tissue Samples for Cancer Research

  • Roswell Park Cancer Institute, Buffalo
피험자 모집 중관찰 연구
2 Months · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT00900198

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Roswell Park Center Institute, Buffalo
  • NYU Langone Health, New York
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07002034

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06953960

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06756607

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • Icahn School of Medicine At Mount Sinai, New York
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • 외 2개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06634589

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Commack
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482

Exercise and Cognitive Rehab in Older Cancer Survivors

  • University of Rochester, Rochester
피험자 모집 중
60세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05388214

Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors

  • University of Rochester, Rochester
피험자 모집 중
65세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT07390045

A Single Arm Pilot Trial of a Social Network Intervention

  • University of Rochester, Rochester
피험자 모집 중
60세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT05745038

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.